Ono Venture Investment

Harness Therapeutics is a developer of a platform for physiological upregulation of proteins using targeted translation enhancers, SINEUPs.

AIRNA is a biotech company that is pioneering RNA editing therapies to improve the health of individuals.

Mozart is a biotech startup focusing on the development of disease-modifying therapies for autoimmune and inflammatory diseases.

Violet Therapeutics is a pre-clinical stage company leveraging first-in-class platforms to identify, map, and mine the cellular connectome.

Curreio is a biotechnology platform that provides contract business for structural analysis using cryo-electron microscopy.

Mediar is a pre-clinical stage biotechnology company developing therapeutics for the treatment of fibrosis.

Switch Therapeutics is a biotech company that develops RNAi therapies.

Casma Therapeutics is a biotechnology company harnessing the natural cellular process of autophagy to design new medicines.

Photys Therapeutics’ proprietary bifunctional small molecules platform unlocks fine-tuned control of protein modifications.

Arbor Biotechnologies is an operator of a bio-discovery company intended to provide human diagnostic development services.